Annual Non Current Assets
$3.95 M
+$28.00 K+0.71%
December 31, 2023
Summary
- As of February 21, 2025, VRDN annual long term assets is $3.95 million, with the most recent change of +$28.00 thousand (+0.71%) on December 31, 2023.
- During the last 3 years, VRDN annual non current assets has risen by +$2.30 million (+140.02%).
- VRDN annual non current assets is now at all-time high.
Performance
VRDN Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$4.54 M
+$544.00 K+13.60%
September 30, 2024
Summary
- As of February 21, 2025, VRDN quarterly long term assets is $4.54 million, with the most recent change of +$544.00 thousand (+13.60%) on September 30, 2024.
- Over the past year, VRDN quarterly non current assets has dropped by -$375.00 thousand (-7.63%).
- VRDN quarterly non current assets is now -11.55% below its all-time high of $5.14 million, reached on June 30, 2023.
Performance
VRDN Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
VRDN Non Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +0.7% | -7.6% |
3 y3 years | +140.0% | -7.6% |
5 y5 years | +407.9% | -7.6% |
VRDN Non Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +11.3% | -11.6% | +40.9% |
5 y | 5-year | at high | +654.5% | -11.6% | +768.6% |
alltime | all time | at high | -100.0% | -11.6% | -100.0% |
Viridian Therapeutics Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $4.54 M(+13.6%) |
Jun 2024 | - | $4.00 M(+12.2%) |
Mar 2024 | - | $3.56 M(-9.7%) |
Dec 2023 | $486.48 M(+12.8%) | $3.95 M(-19.8%) |
Sep 2023 | - | $4.92 M(-4.2%) |
Jun 2023 | - | $5.14 M(+27.1%) |
Mar 2023 | - | $4.04 M(+3.1%) |
Dec 2022 | $431.17 M(+115.4%) | $3.92 M(+21.5%) |
Sep 2022 | - | $3.23 M(-12.0%) |
Jun 2022 | - | $3.66 M(-3.0%) |
Mar 2022 | - | $3.78 M(+6.5%) |
Dec 2021 | $200.16 M(+54.4%) | $3.55 M(+8.6%) |
Sep 2021 | - | $3.27 M(+19.2%) |
Jun 2021 | - | $2.74 M(+111.1%) |
Mar 2021 | - | $1.30 M(-21.0%) |
Dec 2020 | $129.61 M(+335.8%) | $1.64 M(+90.9%) |
Sep 2020 | - | $861.00 K(-10.7%) |
Jun 2020 | - | $964.00 K(+36.0%) |
Mar 2020 | - | $709.00 K(+35.6%) |
Dec 2019 | $29.74 M | $523.00 K(-12.2%) |
Sep 2019 | - | $596.00 K(-15.1%) |
Jun 2019 | - | $702.00 K(-5.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2019 | - | $741.00 K(-4.6%) |
Dec 2018 | $65.37 M(+26.0%) | $777.00 K(-3.0%) |
Sep 2018 | - | $801.00 K(+20.6%) |
Jun 2018 | - | $664.00 K(+3.9%) |
Mar 2018 | - | $639.00 K(+4.2%) |
Dec 2017 | $51.87 M(+1117.8%) | $613.00 K(-7.1%) |
Sep 2017 | - | $660.00 K(-2.4%) |
Jun 2017 | - | $676.00 K(-20.9%) |
Mar 2017 | - | $855.00 K(>+9900.0%) |
Dec 2016 | $4.26 M(-63.7%) | $0.00(-100.0%) |
Sep 2016 | - | $1.03 M(-4.4%) |
Jun 2016 | - | $1.08 M(-4.3%) |
Mar 2016 | - | $1.12 M(-3.8%) |
Dec 2015 | $11.73 M(+72.9%) | $1.17 M(-2.0%) |
Sep 2015 | - | $1.19 M(-3.5%) |
Jun 2015 | - | $1.24 M(-1.7%) |
Mar 2015 | - | $1.26 M(-3.7%) |
Dec 2014 | $6.79 M(+230.2%) | $1.30 M(+50.0%) |
Sep 2014 | - | $869.20 K(-2.9%) |
Jun 2014 | - | $895.00 K(-53.1%) |
Mar 2014 | - | $1.91 M(+18.0%) |
Dec 2013 | $2.06 M(+23.5%) | $1.62 M |
Dec 2012 | $1.66 M | - |
FAQ
- What is Viridian Therapeutics annual long term assets?
- What is the all time high annual non current assets for Viridian Therapeutics?
- What is Viridian Therapeutics annual non current assets year-on-year change?
- What is Viridian Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly non current assets year-on-year change?
What is Viridian Therapeutics annual long term assets?
The current annual non current assets of VRDN is $3.95 M
What is the all time high annual non current assets for Viridian Therapeutics?
Viridian Therapeutics all-time high annual long term assets is $3.95 M
What is Viridian Therapeutics annual non current assets year-on-year change?
Over the past year, VRDN annual long term assets has changed by +$28.00 K (+0.71%)
What is Viridian Therapeutics quarterly long term assets?
The current quarterly non current assets of VRDN is $4.54 M
What is the all time high quarterly non current assets for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly long term assets is $5.14 M
What is Viridian Therapeutics quarterly non current assets year-on-year change?
Over the past year, VRDN quarterly long term assets has changed by -$375.00 K (-7.63%)